|
May 17
|
Chemomab Therapeutics to Participate in Upcoming Scientific Conferences
|
|
Feb 20
|
Chemomab Awarded New Patents for CM-101, Its First-in Class Monoclonal Antibody in Clinical Development for Fibro-Inflammatory Diseases
|
|
Aug 29
|
Chemomab Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
|
|
Apr 26
|
Chemomab Therapeutics to Present at 2023 Aegis Virtual Conference
|